ABSTRACT SRC-related tyrosine kinases are suggested to play a role in the increase of sperm protein phosphotyrosine content that occurs during capacitation. In our laboratory, we previously demonstrated that the SRC-related tyrosine kinase YES1 (also known as c-YES) is present in human spermatozoa. However, since it is negatively regulated by Ca 2þ , whose intracellular concentration increases during capacitation, another kinase would most likely be involved in the capacitation-related increase in sperm protein tyrosine phosphorylation. The present study represents the first direct assessment of SRC tyrosine kinase activity in ejaculated mammalian sperm. By immunohistochemistry on human testis sections, it is clearly shown that SRC is expressed during spermatogenesis, mainly in round and elongating spermatids. Using an indirect immunofluorescence approach, SRC is detected in the acrosomal region of the head and in the sperm flagellum of ejaculated sperm. This tyrosine kinase is associated with the plasma membrane and with cytoskeletal elements, as suggested by its partial solubility in nonionic detergents. Despite its partial solubility, SRC kinase activity was assayed after immunoprecipitation using acid-denatured enolase as a substrate. It is clearly demonstrated that SRC activity is inhibited by SU6656 and PP1, selective SRC family tyrosine kinase inhibitors, and activated in a Ca 2þ -dependent manner. Furthermore, it is shown that SRC is activated in a cAMP/PRKA-dependent manner; SRC coimmunoprecipitates with the catalytic subunit of the cAMP-dependent protein kinase (PRKAC) and is phosphorylated by this latter kinase, resulting in an increase in enolase phosphorylation. All these results support the involvement of the tyrosine kinase SRC in the increase in sperm protein phosphotyrosine content observed during capacitation.
INTRODUCTION
During capacitation, spermatozoa go through a whole set of membrane and intracellular biochemical events in order to successfully fertilize the egg [1] . Mature spermatozoa are terminally differentiated and specialized cells whose activities rely mainly on posttranslational modifications of pre-existing proteins, such as protein phosphorylation and dephosphorylation. In somatic cells, phosphorylation of proteins is an essential process in the regulation of cellular growth, cell cycle and differentiation, cytoskeleton assembly, ionic current, and receptor activity [2, 3] . Phosphorylation occurs on serine, threonine, and tyrosine residues in proteins. Although protein phosphorylation on serine/threonine and on tyrosine residues have been reported and investigated, protein tyrosine phosphorylation is currently the most studied type of posttranslational modification in the field of sperm capacitation.
In fact, it has been shown that increases in protein tyrosine phosphorylation occur during capacitation of spermatozoa from various species, including humans [4] [5] [6] [7] , mice [8] [9] [10] , hamsters [11, 12] , bovine [13] , pigs [14] , and many others [15] [16] [17] [18] [19] . All these studies provide evidence that protein tyrosine phosphorylation is an important posttranslational modification that regulates events associated with sperm capacitation.
It has been observed that different compartments of human spermatozoa undergo a specific sequence of phosphorylation during capacitation and upon binding to the zona pellucida [20] . The flagellum appears as the major cell compartment that undergoes tyrosine phosphorylation in association with the acquisition of hyperactive motility [18, 21, 22] . In human spermatozoa, protein tyrosine phosphorylation occurs mainly in the principal piece [6, 23] , and two fibrous sheath proteins, p105 and p81, are the major proteins that phosphotyrosine content increases during capacitation [5] [6] [7] 24] . Calciumbinding and tyrosine phosphorylation-regulated protein (CA-BYR) also localizes to the principal piece of the human sperm flagellum in association with the fibrous sheath. This protein gains calcium-binding capacity when phosphorylated during capacitation [25] which, again, suggests an involvement of protein tyrosine phosphorylation in the control of sperm motility.
In addition to the flagellar protein tyrosine phosphorylation, capacitation-related increases in the phosphotyrosine content of human sperm head proteins have also been observed [4, 20, 26] . This suggests a role for this posttranslational modification in the acrosomal exocytosis of sperm cells and their interactions with the egg's zona pellucida. Proteins such as heat shock 90-kDa protein (HSP90AA1) [27] , heat shock 60-kDa protein 1 (HSPD1), and heat shock protein 90-kDa beta (Grp94; HSP90B1) [28] are tyrosine phosphorylated, and the latter two have been suggested to participate in mouse sperm zona binding. In human, MAPK3 and MAPK1 (extracellular signal-regulated kinases [ERKs] 1 and 2) have also been reported to be tyrosine phosphorylated and activated during sperm capacitation [29] .
The mechanisms involved in the modulation of sperm protein phosphotyrosine content during capacitation have been shown to result from the crosstalk between different signaling pathways. Previous studies in spermatozoa from different species have demonstrated that the increase in protein phosphotyrosine content during capacitation is modulated by the cAMP-dependent pathway [5, 7, 10, 11, 13, 16] and by oxygen derivatives [6, [30] [31] [32] [33] . Conflicting results, however, have been reported according to the effects of Ca 2þ on sperm protein tyrosine phosphorylation. Some reports have documented that extracellular Ca 2þ is required for the capacitationmediated increase in protein tyrosine phosphorylation [7, 9] , whereas other studies have demonstrated that Ca 2þ negatively regulates protein tyrosine phosphorylation [23, 34, 35] . However, results from our laboratory show that this differential effect depends on the intracellular compartmentalization of Ca 2þ , cytosolic Ca 2þ being required for the increase in protein tyrosine phosphorylation while stored Ca 2þ prevents this type of phosphorylation [36] . However, as an increase in sperm intracellular Ca 2þ is an important event in sperm capacitation [37, 38] , this event might be related, either directly or indirectly, to the increase in protein tyrosine phosphorylation observed during sperm capacitation.
Protein tyrosine phosphorylation directly depends on the concerted activities of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). The capacitation-related increase in sperm protein phosphotyrosine content might occur through the activation of PTK, the inhibition of PTP, or both. The observed decrease in protein tyrosine phosphorylation when spermatozoa were incubated with PTK inhibitors, such as herbimicyn A, erbstatin, SU6656, PP1, or PP2 [6, 24, 36, 39] , which are directed more specifically to SRC-related tyrosine kinases, strongly suggest the involvement of this family of tyrosine kinases in capacitation-mediated increases in sperm protein phosphotyrosine content. The involvement of SRCrelated PTKs is also supported by the stimulatory effects of oxygen derivatives on sperm protein tyrosine phosphorylation [6] . It has been shown that SRC-related PTKs are activated by oxygen derivatives [40, 41] .
In our laboratory, we previously demonstrated that the SRCrelated tyrosine kinase YES1 (c-YES) is present in human spermatozoa [42] . However, since it was negatively regulated by the presence of Ca 2þ and as an increase of intracellular Ca 2þ occurs during capacitation, another SRC-related kinase would most likely be involved in the capacitation-related increase in sperm protein phosphotyrosine content. The c-SRC is positively regulated by Ca 2þ [43] , and its presence has been reported recently in mouse sperm [39] and in human sperm [44] . However, direct assessment of SRC kinase activity needs to be further investigated. Therefore, the objective of the present study is to specifically characterize the kinase activity of c-SRC in human spermatozoa and to unveil the mechanisms underlying its regulation.
MATERIALS AND METHODS

Immunohistochemistry
All experiments involving human testis tissues were approved by the hospital (CHUQ) and Laval University ethics committees for research on human subjects. Human testes were obtained from 26-to 60-year-old men registered in our local organ transplantation program. These donors were victims of accidental death and did not show any pathology that could affect their reproductive function. Tissues were collected while artificial circulation was maintained to preserve organs and tissues assigned for transplantation. Pieces of human testis were taken underneath the tunica albuginae, fixed in a commercial formaldehyde solution (ACP Chemicals Inc., Montreal, QC, Canada), and embedded in paraffin by the hospital pathology department.
Immunohistochemistry was performed on 5-lm-thick sections. The slides were deparaffined and rehydrated through successive incubations in baths with decreasing concentrations of ethanol. At the end, they were bathed in water. The testis sections were washed in PBS (1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 , 137 mM NaCl, and 2.7 mM KCl, pH 7.4), and endogenous peroxidase activity was inhibited by 3% H 2 O 2 in methanol for 10 min. Antigen retrieval was achieved by incubation of the slides for 10 min in a boiling bath containing 10 mM sodium citrate, pH 6.0. Nonspecific sites were blocked with 1% BSA in PBS for 1 h. The slides were then incubated overnight at 48C in the presence of the c-SRC polyclonal antibody (N-16; Santa Cruz Biotechnology Inc., Santa Cruz, CA) diluted at 5 lg/ml in the blocking solution or with a polyclonal antiacrosin binding protein (ACRBP) to identify the developing acrosomes in the seminiferous tubules (a generous gift from Dr. Tadashi Baba, University of Tsukuba, Ibaraki, Japan) [45] . After being washed five times with PBST (PBS supplemented with 0.05% Tween-20), the sections were incubated with a biotin-conjugated donkey anti-rabbit immunoglobulin G (IgG) in the blocking solution for 1 h at room temperature, washed again in PBST, and incubated with horseradish peroxidase-conjugated streptavidin for 45 min at room temperature (both from Jackson ImmunoResearch Laboratories Inc., West Grove, PA). The slides were extensively washed in PBST, and the immune complex was revealed with 3,3 0 -diaminobenzidine (DAB; Sigma-Aldrich, Oakville, ON, Canada) and counterstained with hematoxylin. At last, the tissue sections were mounted in Mowiol and observed by light microscopy (Zeiss Axioskop 2). Testis sections incubated with the same concentration of commercial nonimmune rabbit IgGs (Sigma) were used as negative controls.
Preparation and Incubation of Human Spermatozoa
Ejaculates were obtained by masturbation from healthy volunteers after a minimum of 2 days of sexual abstinence. All sperm donors gave informed written consent, and approval was obtained from the hospital (CHUQ) and Laval University ethics committees for research on human subjects. Only the samples with normal sperm parameters according to the World Health Organization [46] criteria were used. After liquefaction, the semen was layered on top of a gradient composed of 2-ml fractions each of 20%, 40%, and 65% and 0.1 ml of 95% Percoll (GE Healthcare Bio-Sciences Inc., Baie d'Urfé, QC, Canada) made isoosmotic in a HEPES-buffered saline (HBS; 25 mM Hepes, 130 mM NaCl, 4 mM KCl, 0.5 mM MgCl 2 , 14 mM fructose, pH 7.6) and was centrifuged (30 min, 1000 3 g) to wash the spermatozoa from the seminal plasma. Sperm cells at the 65%-95% interface and within the 95% Percoll fraction were collected, counted to evaluate sperm concentration, and diluted to 20 3 10 6 /ml in Biggers-Whitten-Whittingham (BWW) medium slightly modified from the original formulation [47] (94.6 mM NaCl, 4.8 mM KCl, 1.7 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 25.1 mM NaHCO 3 , 5.6 mM glucose, 21.6 mM sodium lactate, 0.25 mM sodium pyruvate, 0.1 mg/ml phenol red, and 10 mM HEPES, pH 7.6) supplemented with 3 mg/ml BSA (BWW/BSA). Sperm were incubated at 378C (5% CO 2 in air, 100% humidity). In a specific experiment, the SRC tyrosine kinase inhibitors, SU6656 (Sigma) and PP1 (Biomol International LP, Plymouth Meeting, PA), or pyridone 6 (P6; Calbiochem, La Jolla, CA), a pan-Janus-activated kinase (JAK) inhibitor, were added to the sperm suspension. Aliquots containing 1 3 10 6 spermatozoa were taken at different times during the incubation, and proteins were solubilized in electrophoresis sample buffer (62.5 
Subcellular Fractionation
Subcellular fractions of Percoll-washed human sperm were obtained through the membrane isolation procedure described by Noland et al. [48] . The complete procedure was performed at 48C. Spermatozoa were supplemented with protease inhibitors (250 lM phenylmethanesulphonylfluoride [PMSF] and 10 lg/ml each of aprotinin, pepstatin A, and leupeptin; Sigma) and subjected to nitrogen cavitation at 500 psi for 10 min. The suspension was collected slowly (total) and was next centrifuged at 10 000 3 g for 20 min. The supernatant was further centrifuged at 100 000 3 g for 1 h to isolate the plasma membrane fraction (pellet) and cytosolic fraction (supernatant). The pellet obtained from the first 10 000 3 g centrifugation was resuspended in HBS and sonicated (2 3 15 sec) on ice to separate the heads from the flagella. The sonicated suspension was then subjected to centrifugation at 700 3 g for 15 min through a 75% Percoll layer made in HBS in order to recuperate other membranes (supernatant) that were recovered by another 1-h centrifugation at 100 000 3 g, the heads (pellet), and the flagellar (interface) fractions. Heads and flagellar fractions were resuspended in HBS and collected upon a 10 000 3 g centrifugation. Aliquots were taken at each step of the procedure. Proteins from the cytosolic fraction were concentrated using a Microcon YM-10 Centrifugal 658 LAWSON ET AL.
Filter Unit (Millipore, Billerica, MA). Proteins were solubilized in sample buffer and heated at 1008C for 5 min. Particulate material was removed by centrifugation (10 000 3 g, 5 min, 48C). Protein concentration was determined using the Micro BCA Protein Assay kit (Pierce Biotechnology Inc., Rockford, IL) after precipitation with trichloroacetic acid to get rid of the detergents and reducing agents. The presence of SRC was investigated by Western blot on equal amounts of proteins from each fraction.
Immunoprecipitation Kinase Assay of SRC in Human Spermatozoa
Tyrosine kinase activity was assayed in the immune complex using the v-SRC monoclonal antibody (mab327; Calbiochem) and nonimmune mouse IgGs (Sigma) as a negative control. At different times during the incubation, the sperm suspension was centrifuged for 5 min at 500 3 g at room temperature and resuspended (100 3 10 6 sp/ml) in immunoprecipitation buffer (IP buffer; 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% NP-40, 1 mM CaCl 2 , 0.2 mM Na orthovanadate, 250 lM PMSF, 10 lg/ml leupeptin, 10 lg/ ml aprotinin, and 10 lg/ml pepstatin A), kept on ice for 30 min, and frequently vortexed to facilitate kinase extraction. The homogenate was centrifuged (10 000 3 g, 48C, 20 min), and the soluble fraction was next incubated at 48C with end-over-end rotation for 2 h in the presence of 1 lg of SRC antibody or of nonimmune mouse IgGs as a control. The immune complex was pelleted with the Protein G-coupled sepharose beads (GE Healthcare) after 2 h of incubation at 48C with end-over-end rotation. The beads were washed three times by centrifugation with IP buffer and then resuspended in the kinase buffer (10 mM Tris-HCl, pH 7.4; 150 mM NaCl; 10 mM MgCl 2 ; 2.5 mM MnCl 2 ; 0.5 mM DTT; and 0.1 mM Na orthovanadate). The kinase assay was performed at 308C for 10 min in the presence of 5 lM ATP and 10 lCi [ 32 P]cATP (Perkin Elmer, Waltham, MA) in the absence or presence of 2.5 lg acid-denatured rabbit muscle enolase (Sigma) to discriminate between autophosphorylation and kinase activity, respectively. The phosphorylation reaction was stopped by the addition of concentrated electrophoresis solubilization buffer, and the proteins were heated for 5 min at 1008C and separated by SDS-PAGE. The gels were stained with Coomassie Brilliant Blue and allowed to dry, and the phosphorylated proteins were visualized by autoradiography at À808C using intensifying screens or were scanned/digitalized using Bio-Rad's phosphor screens and Personal Molecular Imager system (Bio-Rad, Hercules, CA). Protein phosphorylation was quantified using Bio-Rad's Quantity One 1-D analysis software. SRC kinase activity was measured on spermatozoa incubated in the presence or absence of 500 lM IBMX to prevent intracellular cAMP degradation, with 1 mM dibutyryl cyclic AMP (dbcAMP; Biomol), a cellpermeant cAMP analog, with 10 or 50 lM of the PRKA inhibitor H-89 (Biomol), or with 10 lM of SU6656 or PP1 to inhibit SRC activity, or with 100 nM P6, an inhibitor of the tyrosine kinase JAK. To study the effect of Ca 2þ on SRC activity, sperm were incubated in BWW medium devoid of Ca 2þ and containing 1 mM of the Ca 2þ chelator 1,2-bis(2-aminophenoxy)-ethane-N,N,N 0 ,N 0 -tetracetic acid (BAPTA). In this latter condition, the IP buffer was supplemented with 1 mM EDTA and 1 mM EGTA instead of 1 mM CaCl 2 .
Indirect Immunofluorescence
A total of 35 ll of a 20 3 10 6 cells/ml suspension of washed human sperm or sperm extracted with the IP buffer were deposited on coverslips coated with poly-L-lysine (Sigma) and allowed to settle for 30 min at room temperature. Spermatozoa were then fixed for 15 min with 3.7% formaldehyde in PBS, rinsed with PBS, permeabilized for 10 min with 0.2% Triton X-100 in PBS (except for the spermatozoa already solubilized in IP buffer), and rinsed again with PBS. Nonspecific sites were blocked with PBS supplemented with 1% BSA. Samples were then incubated overnight at 48C with 5 lg/ml of the c-SRC polyclonal antibody diluted in the blocking solution, rinsed with PBS, and incubated with an AlexaFluor 568-labeled goat anti-rabbit secondary antibody (Molecular Probes, Invitrogen, Burlington, ON, Canada). Two types of controls were used in these studies: nonimmune rabbit IgGs instead of the primary antibody, and SRC antibody preadsorbed with its immunizing peptide (Santa Cruz Biotechnology). Following washes with PBS, the coverslips were mounted on slides with 90% glycerol containing an antifading agent (1.5% DABCO; Sigma). Immunofluorescence signal was detected by epifluorescence microscopy with an ultraviolet light.
PRKA-SRC Interactions
Percoll-washed human spermatozoa were resuspended in IP buffer supplemented with protease inhibitors for 30 min on ice and were vortexed every 5 min. Solubilized proteins were collected by a 20-min centrifugation at 10 000 3 g at 48C as described above. Either 1 lg anti-SRC (mab327) or anticatalytic subunit of the cAMP-dependent protein kinase (PRKAC; BD Biosciences, Mississauga, ON, Canada) monoclonal antibodies was added to the suspension and was incubated for 2 h at 48C with end-over-end rotation. Protein G-coupled Sepharose beads were added and incubated with rotation for 2 h at 48C. The immune complex associated with the beads was pelleted by centrifugation (3 min at 4500 3 g at 48C) and washed three times by centrifugation with the IP buffer. The beads were next resuspended with electrophoresis sample buffer and heated at 1008C. Proteins were precleared using 1 lg nonimmune mouse IgGs and Protein G-coupled Sepharose beads as a negative control before IP with specific antibodies. The presence of the PRKA catalytic subunit was investigated in the SRC immunoprecipitate by Western blot procedure using the antibody directed toward PRKAC.
PRKAC In Vitro Assay
Percoll-washed human spermatozoa were resuspended in IP buffer supplemented with protease inhibitors for 30 min on ice and were vortexed every 5 min. Solubilized proteins were collected by a 20-min centrifugation at 10 000 3 g at 48C as described above. PRKAC kinase assay buffer was added to the solubilized fraction (final concentrations: ATP 100 lM; 10 mM TrisHCl, pH 7.4; 150 mM NaCl; 10 mM MgCl 2 ; 2.5 mM MnCl 2 ; 0.5 mM DTT; 0.1 mM Na orthovanadate; 0.5 mM NaF; 250 lM PMSF; 10 lg/ml leupeptin; 10 lg/ml aprotinin; and 10 lg/ml pepstatin A). The assay was performed in the absence or the presence of 5 units of commercial bovine heart PRKAC (Sigma) at 308C for 30 min. SRC imunoprecipitation was then performed at 48C. Proteins were first precleared using 1 lg nonimmune mouse IgGs and Protein G-coupled Sepharose beads as a negative control before IP with specific SRC monoclonal antibody (mab327). The immune complex was used to assess SRC kinase activity (described above) or to assess PRKA-dependent SRC phosphorylation by Western blot using a monoclonal anti-phospho-PRKA substrate (Cell Signaling, Pickering, ON, Canada).
Western Immunoblotting
Solubilized proteins were separated by 7.5% SDS-PAGE under reducing conditions [49] and electrotransferred on polyvinylidene fluoride (PVDF) membrane (Millipore) [50] . 
RESULTS
Testicular Expression of SRC
The expression of SRC during spermatogenesis was assessed by immunohistochemistry on human testis sections. This tyrosine kinase is expressed in both the seminiferous tubules and the interstitial tissues (Fig. 1A) . This result is not surprising, since this protein is known to be ubiquitously expressed. Within the seminiferous tubules, SRC is strongly expressed in round and elongating spermatids in a crescent shape surrounding the nucleus, suggesting an association with acrosomal structures or its presence within the acrosome (Fig.  1B) . This tyrosine kinase is barely detectable at earlier stages of spermatogenesis, in spermatocytes or spermatogonia. To confirm the localization of SRC at the acrosomal region of round and elongating spermatids, the same protocol was used with an affinity-purified antibody directed against the ACRBP that specifically localizes to the acrosome [45] (Fig. 1, C and  D) .
SRC ACTIVITY IN HUMAN SPERM
The Tyrosine Kinase SRC in Human Ejaculated Spermatozoa Cellular localization of SRC in mature human sperm was next assessed by indirect immunofluorescence. As shown in Figure 2A , a positive signal is observed in the acrosomal region of the sperm head and the entire flagellum. Preabsorption of the antibody with the immunizing peptide showed no signal, confirming the specificity of the antibody (Fig. 2E) . Commercial nonimmune rabbit IgGs were also used as a negative control and showed no positive signal (data not shown). Western blot analysis on sperm subcellular extracts clearly showed that SRC is detected mostly in the plasma membraneenriched fraction (Fig. 3A) . Furthermore, when spermatozoa were solubilized with nonionic detergents (IP buffer), which will be used for the specific IP and tyrosine kinase assay of SRC, this kinase was partially extracted (Fig. 3B) . Although SRC was still detected in the head and flagellum after detergent extraction, most of the signal present in the acrosomal region was lost (Fig. 2C) . This suggests that in the sperm acrosomal region, SRC is associated with the membranes.
SRC Kinase Activity in Human Spermatozoa
Human sperm SRC tyrosine kinase activity was next investigated after IP. Using denatured rabbit muscle enolase as a substrate, no or weak kinase activity was detected when the assay was performed upon sperm incubation and SRC IP in the absence of Ca 2þ (Fig. 4, lanes 1 and 2) . However, when sperm were incubated in the presence of Ca 2þ (Fig. 4, lanes 3  and 4) , the phosphorylation of enolase by immunoprecipitated SRC was easily detected. This difference in SRC tyrosine kinase activity could not be attributed to a lesser amount of the kinase itself, as none of the treatments affected the solubilization of SRC (data not shown). This supports the idea that sperm SRC kinase activity is Ca 2þ dependent. The specificity of the tyrosine kinase assay toward SRC was next assessed using different tyrosine kinase inhibitors. As shown in Figure 5A , when human spermatozoa were incubated for 4 h under capacitating conditions, an increase in the phosphotyrosine content of specific sperm proteins, such as p81 and p105, was observed. However, when the incubation was done in the presence of SU6656 or PP1, specific inhibitors of the SRC kinase family, the rise in the phosphotyrosine content of those proteins was blocked, whereas P6, a pan-JAK kinase inhibitor which inhibits JAK family kinases at a low nanomolar range (IC 50 , 1-15 nM) [51] , had no effect, even at concentrations up to 5 lM. No effect on sperm motility was observed in any of these treatments (data not shown). This suggests that this increase in sperm protein tyrosine phosphorylation is due to the activity of the SRC kinase family.
FIG. 1. Expression of SRC in human testis.
Immunohistochemistry was performed using the SRC or the sp32 polyclonal antibody and revealed using a biotinylated secondary antibody and horseradish peroxidase-conjugated streptavidin. The cellular localization of SRC and ACRBP was visualized with DAB and appears as a brown precipitate. A and B show SRC expression at 3200 and 31000, and C and D show sp32 at 3200 and 31000, respectively. No signal was observed when commercial rabbit IgGs were used as a negative control (original magnifications 3200 [E] and 31000 [F]). The immunodetection of SRC was performed on testicular sections from three different donors with identical results. Scale bars at 3200 and 31000 represent 50 lm and 10 lm, respectively.
LAWSON ET AL.
Moreover, when the IP kinase assay was performed in the presence of SU6656, a significant decrease in SRC activity was observed (P , 0.05), whereas no effect was observed when the assay was done in the presence of P6 (negative control; Fig.  5B) . A decrease in SRC activity was also significant in the presence of PP1 (P , 0.001; Fig. 5C ). This correlates with the decrease in the phosphotyrosine content shown in Figure 5A and supports our hypothesis that SRC plays a role in the increase of the phosphotyrosine content of specific human sperm proteins.
Effect of the cAMP-Dependent Pathway on SRC Kinase Activity
Immunoprecipitation kinase assays were next performed on spermatozoa incubated for different periods of time under capacitating conditions. A transient increase in SRC kinase activity was detected at 1 h (Fig. 6, A and B) . When spermatozoa were incubated with the phosphodiesterase inhibitor IBMX to prevent cAMP catabolism, a treatment that has been shown to induce increases in sperm capacitation, motility, and protein phosphotyrosine content [5, 32] , a higher SRC kinase activity was measured (P , 0.01; Fig. 6B ). The difference in the kinase activity could not be attributed to differences in the amounts of the kinase itself, as none of the treatments affected the solubilization of SRC subjected to the IP kinase assay (data not shown). The IBMX effect was rapid (Fig. 6A, lane 1 vs. lane 6) , as the increase in SRC activity was significant (P , 0.01) immediately at the beginning of the incubation. For this first measure of kinase activity, the cells were in the presence of IBMX for ;7 min due to the centrifugation and extraction procedures. As Western blot analyses revealed no increase in the SRC kinase content in the protein extract subjected to the IP kinase assay, the increase in enolase phosphorylation most likely results from a higher SRC kinase activity. To confirm the role of cAMP on SRC tyrosine kinase activity, the sperm cells were incubated under capacitating conditions in the presence of dbcAMP, a cellpermeant cAMP analog. As shown in Figure 6C , even though we did not observe any differences in sperm motility after 1 h of incubation (data not shown), dbcAMP significantly increased SRC activity (P , 0.05). These results suggest that SRC activity is positively modulated by cAMP.
To further investigate the effect of the cAMP on sperm SRC kinase activity, the PRKA inhibitor H-89 was used to determine whether cAMP actions are mediated by PRKA. As shown in Figure 6D , a significant dose-dependent decrease in SRC kinase activity is measured when H-89 is present at 10 and 50 lM (P , 0.01). No difference in sperm motility was observed in these conditions (data not shown). These results
FIG. 2. Immunolocalization of SRC in human spermatozoa. A)
Washed spermatozoa were fixed/permeabilized and SRC was localized using the SRC polyclonal antibody. C) Spermatozoa were first extracted with the IP buffer before fixation, and the detection of SRC was next processed as in A. No signal was observed when the antibody was preadsorbed with the immunizing peptide prior to sperm immunodetection (E) or when commercial rabbit IgGs were used as a negative control (not shown). Arrows point to the positive signal to the acrosomal region of the sperm head and the entire flagellum (A, C). Corresponding fields observed by phase-constrast microscopy are shown (B, D, F) . Picture is representative of more than three replicates with identical results shown. Bar ¼10 lm.
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The interaction of the tyrosine kinase SRC with PRKA was next assessed by coimmunoprecipitation. The catalytic subunit of PRKA (PRKAC) is present within the SRC immunoprecipitated complex from human sperm (Fig. 7A) . Furthermore, when PRKAC was added to the sperm lysate prior to SRC IP under conditions sustaining PRKAC activity, SRC was detected by an anti-phospho-PRKA substrate antibody (Fig.  7B, lane 2) . This suggests that in human sperm, SRC is phosphorylated by PRKAC. After such a procedure, when SRC activity was assessed, a significant increase in enolase phosphorylation was measured when the sperm lysate was added with PRKAC prior to SRC IP (Fig. 7C) . As an alternative, to determine whether PRKA affects SRC's activity indirectly through phosphorylation of the C-terminal SRC kinase (CSK), the presence of the latter was next assessed in human spermatozoa and Western blot analysis clearly shows its presence in sperm extracts (Fig. 7D) .
DISCUSSION
The aim of this study was to determine whether the protein tyrosine kinase SRC is involved in the capacitation-associated increase in protein phosphotyrosine content. The results presented in this study clearly demonstrate that it is present and active in mature ejaculated human spermatozoa. Furthermore, for sperm capacitation, its activity requires Ca 2þ and is stimulated by the cAMP/PRKA pathway. This study is the first direct demonstration that the tyrosine c-SRC is active in human spermatozoa. Using an antibody that recognizes the activated forms of several members of SRC-related kinases, it was suggested that SRC is activated during mouse and human sperm capacitation [39, 44] . Since the antibody used by this group reacts with a specific phosphor-tyrosine residue within the autophosphorylation domain, and as the amino sequence surrounding that specific tyrosine residue is highly conserved in all members of the SRC family in different species, the identity of the specific kinase activated could not be established. Our study where the protein kinase activity of SRC is evaluated after IP is in agreement with the previous studies. Furthermore, it confirms that c-SRC is an active protein kinase in human sperm.
Within the seminiferous tubules, a high expression of SRC is observed at the spermatid stage, where it is found mostly associated with the developing acrosome. In mature ejaculated spermatozoa, SRC is associated with the membrane-enriched fractions and is localized both to the acrosome and the flagellum. The presence of SRC in the sperm membraneenriched fraction differs from the previous studies cited above. In their assay, the detection of SRC was not attempted in the membrane fraction [39, 44] . Since SRC is a myristoylated protein, its association with cellular membranes is widely accepted [52] , and our results are in perfect agreement with such an association. The presence of SRC in the flagellum has also recently been reported in mouse and human sperm [39, 44] . Tyrosine phosphorylation of sperm proteins has been observed in the acrosomal region as well as in the flagellum of human sperm [4, 20, 26, 53] . This suggests that SRC may play a role in the increase of tyrosine phosphorylation within those two compartments and that it could participate in the processes FIG. 3 . Subcellular distribution of the tyrosine kinase SRC. A) Washed sperm were subjected to subcellular fractionation as described in Materials and Methods. A total of 3 lg of proteins from each fraction were subjected to SDS-PAGE. B) Washed spermatozoa were extracted in the IP buffer containing nonionic detergents. Each lane contains the proteins from 1 3 10 6 spermatozoa that were separated by SDS-PAGE. Gels from these two experiments were electrotransferred to PVDF and probed with SRC monoclonal antibody. These experiments were carried out on sperm samples from three separate donors with similar results .  FIG. 4 . Effect of Ca 2þ on sperm SRC kinase activity. Percoll-washed spermatozoa were incubated for 1 h at 378C in BWW medium containing no added CaCl 2 and supplemented with 1 mM of the Ca 2þ chelator BAPTA (lanes 1 and 2) or in complete BWW (1.7 mM CaCl 2 ; lanes 3 and 4). After the incubation, sperm protein extraction and IP with the SRC monoclonal antibody (mab327; lanes 2 and 4) or the mouse commercial IgGs (lanes 1 and 3) was performed as described in Materials and Methods. The immunokinase assay was performed on the immune complex in the presence of enolase. Once the reaction was stopped with electrophoresis sample buffer, the proteins were separated by SDS-PAGE, and the gels were stained by Coomassie Brilliant Blue, dried, and exposed to x-ray films after a 3-h exposure to phosphor screens. An experiment representative of three with similar results is shown. a-SRC, Anti-SRC.
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of capacitation, acrosome reaction, and hyperactivation of sperm motility.
In the present study, it is clearly demonstrated that in mature sperm, SRC is an active tyrosine kinase whose activity is inhibited by SU6656 and PP1, two inhibitors with increased selectivity toward the SRC family of tyrosine kinases [54] [55] [56] . This decrease in SRC activity is in perfect agreement with the observed decrease in the phosphotyrosine content of specific sperm proteins, such as p81 and p105, which was not observed when P6, a non-SRC tyrosine kinase inhibitor, was used. These results suggest that SRC could play an important role in the increase in protein tyrosine phosphorylation that occurs during human sperm capacitation. In mouse sperm, SU6656 has been shown to decrease protein tyrosine phosphorylation and to inhibit hyperactivation [39] . In our study, qualitative evaluation of sperm motility by two experienced colleagues who were not aware of the treatments did not reveal any effect of SU6656 on sperm motility pattern (data not shown), which is in agreement with recently published data [44] .
Our study clearly demonstrates that SRC activity is increased in a Ca 2þ -dependent and cAMP-dependent manner. On the other hand, SRC kinase activity was measured following extraction with nonionic detergents, which resulted in an incomplete extraction of the kinase itself (Fig. 3) . At the present time, it is not known whether the activity of the nonextracted kinase would be affected by Ca 2þ and cAMP similarly to the ones measured here. Another member of the SRC family of tyrosine kinases, YES1 (c-YES), was also found to be partly insoluble in nonionic agents in human spermatozoa. Moreover, it was suggested that the nonextracted kinase is associated with the sperm head cytoskeletal elements, such as the perinuclear theca [42] . Nonsoluble SRC could also be associated with cytoskeletal elements within the head and possibly in nonsoluble fractions of the flagellum, as SRC is still present in these locations after extraction with nonionic detergents (Fig. 2C) . Our results suggest, however, that SRC is closely associated with the membranes, as it is strongly enriched in that subcellular fraction obtained after nitrogen cavitation. Strong protein-protein interactions might explain the association of SRC with cytoskeletal elements and its incomplete extraction by nonionic detergents. This remains to be further investigated in the near future.
The presence of Ca 2þ is essential for SRC kinase activity in human sperm. On the other hand, the effect of Ca 2þ on sperm protein tyrosine phosphorylation is still a matter of conflict. An increase in intracellular Ca 2þ is an important event during sperm capacitation [37, 38] , and this increase would contribute at least partially to the increase in sperm protein tyrosine 
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is shown. No effect of P6 was observed on sperm protein phosphotyrosine content at concentrations up to 100 lM (data not shown). B) Sperm were incubated in complete BWW medium at 378C for 1 h in the absence (white bar) or presence of 10 lM SU6656 (gray bar) or 100 nM P6 (black bar) and processed for SRC IP and kinase assay in the presence of the same inhibitors. The rest of the procedure was performed as described in Figure  4 . The graph shows the relative SRC kinase activity under these conditions as evaluated using the Quantity One software after scanning/digitalizing of the phosphor screens. Values represent mean 6 SEM of four different experiments. Statistical significance was assessed using a Dunnett multiple comparison test following ANOVA. *Significantly different (P , 0.05) from the value measured in BWW medium. C) Sperm were incubated 1 h at 378C in BWW in the absence or presence of 10 lM PP1 and processed as described above. The graph illustrates the quantification of SRC kinase activity in the absence (open bar) or presence (closed bar) of PP1. Values represent mean 6 SEM of three different experiments. Statistical significance was assessed by t-test. *Significantly different (P , 0.001) from the value measured in BWW incubation medium.
phosphorylation [36] . In fact, the presence of Ca 2þ is required for the capacitation-associated increase in protein phosphotyrosine content [7] . In the present study, it is shown that SRC is active throughout the 4-h incubation under conditions conducive to sperm capacitation and intracellular Ca 2þ increase. Under similar conditions, a previous report from our laboratory demonstrated that YES1 (c-YES) is inactivated by Ca 2þ in human sperm [42] , in agreement with observations from other cell types [57] . Unlike YES1 (c-YES), however, SRC activity is Ca 2þ dependent [43] , which agrees perfectly with our findings. The difference in the effect of Ca 2þ on SRC -containing IP buffer, precleared using commercial mouse IgGs and immunoprecipitated with a SRC monoclonal antibody or a monoclonal antibody directed against the catalytic subunit of PRKA (PRKAC) and processed for Western blot using anti-PRKAC antibody after probing the membrane with the horseradish peroxidase-coupled anti-mouse secondary antibody which only revealed IgG's heavy and light chains (data not shown). The arrows indicate the mouse light and heavy IgG chains. The position of PRKAC is indicated on the right. IP, Antibody used for the immunoprecipitation; WB, antibody used for the Western blot. B) Washed sperm were extracted as in A, and the proteins were subjected to in vitro phosphorylation in the absence or presence of 5 units of PRKAC as described in the experimental procedures. The proteins were next precleared and immunoprecipitated with SRC monoclonal antibody as in A, except that the Western blot was performed with a monoclonal phospho-PRKA substrate antibody. ctrl, Control. C) Sperm were processed as described in B, and kinase assay was as described in Figure 4 Statistical significance (P , 0.01) of the IBMX effect over the duration of incubation was assessed by two-way ANOVA. *Significantly different (P , 0.01) from the value measured at the same incubation time in BWW medium as assessed by a Bonferroni posttest following a two-way ANOVA. C) Sperm were incubated 1 h at 378C in BWW in the absence (open bar) or presence (closed bar) of 1 mM dbcAMP and processed as described above for the quantification of SRC kinase activity. Values represent mean 6 SEM of four different experiments. *Significantly different (P , 0.05) from the value measured in BWW medium using a ttest analysis. D) Sperm were incubated in complete BWW medium at 378C for 1 h in the absence (white bar) or presence of 10 (gray bar) or 50 lM H-89 (black bar) and processed for SRC IP and kinase assay. The graph shows the relative SRC kinase activity under these conditions. Values represent mean 6 SEM of five different experiments. *Significantly different (P , 0.01) from the value measured in BWW medium using a Dunnett multiple comparison test following ANOVA.
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and YES1 activities may be due to differences within their SH3 domain [58] . This suggests that YES1 and SRC may act in different signaling pathways and at different moments during capacitation to participate in the increase in protein tyrosine phosphorylation during capacitation.
As mentioned earlier, it is shown that SRC is active throughout capacitation. Even though the changes in SRC activity during capacitation may appear rather small, SRC activity throughout capacitation might explain the linear increase in protein phosphotyrosine content during the 4-h capacitation period [59] . The rapid activation of SRC observed when sperm are incubated with IBMX would accelerate the increase in sperm protein phosphotyrosine content, as previously reported in mice [10] . Furthermore, it is almost certain that all proteins tyrosine phosphorylated are not direct substrates for SRC. SRC kinase might be at the beginning of the tyrosine phosphorylation cascade and not the only tyrosine kinase implicated in this increase, as suggested by the presence of other kinases, such as YES1 (c-YES) [42] .
Using specific inhibitors and cell-permeable analogs, it was demonstrated that the cAMP-dependent pathway and PRKA are involved in that protein tyrosine phosphorylation that occurs during sperm capacitation in numerous species (for review, see Visconti et al. [60] ). The increase in SRC activity in sperm treated with the phosphodiesterase inhibitor IBMX or dbcAMP and its decrease in presence of H-89, a PRKA inhibitor, suggest that SRC is involved in the cAMP-dependent increase in protein phosphotyrosine content observed during sperm capacitation. This is further supported by the coimmunoprecipitation of the catalytic subunit of PRKA with SRC. Cyclic AMP, via PRKA, can activate the tyrosine kinase SRC by different manners. In this study, it is shown that SRC is phosphorylated by PRKA and that PRKA may increase SRC kinase activity (Fig. 7, B and C) . It has been reported that PRKA can directly increase SRC kinase activity through phosphorylation of its serine 17 residue [61] . PRKA can also affect SRC indirectly through phosphorylation of CSK (Cterminal SRC kinase). This latter tyrosine kinase inhibits SRC by phosphorylating its regulatory C-terminal tyrosine 527 residue [62] . It has been shown that PRKA can inhibit CSK and thereby promote the activation of SRC [63] . The presence of CSK has been reported in mouse sperm [39] , and proteomic analysis of a bull sperm fraction with enriched tyrosine phosphorylation activity also revealed the presence of CSK [64] . In the present study, it is clearly shown that CSK is present in human sperm, which supports a putative role in the regulation of SRC by the cAMP/PRKA-mediated signaling pathway. Another mechanism by which cAMP/PRKA can activate SRC is through phosphorylation of the protein tyrosine phosphatase nonreceptor type 1 (PTPN1) [65, 66] . This phosphatase activates SRC through dephosphorylation of SRC's regulatory C-terminal tyrosine 527 residue [67] . Moreover, PTPN1 has been identified in human sperm [26] and, interestingly, a partial overlap in the localization of SRC and PTPN1 at the equatorial segment and the flagellum would suggest a putative modulation of SRC by PTPN1 during human sperm capacitation. However, at the present time the exact mechanism by which PRKA regulates SRC tyrosine kinase activity remains elusive, and further investigations are needed to better understand how these two kinases interact and are involved in sperm capacitation.
The present study clearly demonstrates that the tyrosine kinase SRC is present and active in human spermatozoa. It is localized in the acrosomal region of the head and sperm flagellum, and it is associated with the plasma membrane and cytoskeletal elements. This tyrosine kinase is activated in a Ca 2þ -dependent as well as a cAMP-dependent manner, and this latter effect occurs through PRKA. The tyrosine kinase SRC is a substrate for and coimmunoprecipitates with the catalytic subunit of PRKA. All these results strongly suggest that SRC is involved in the increase in protein phosphotyrosine content that occurs during sperm capacitation.
